Melissa Fountain
Medical · Wheat Ridge, CONPI 1609327493
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 440 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 49 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,355 and has fallen 96.7% since, to $79 in 2025. Among medical clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 440 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Boehringer Ingelheim$758
- AbbVie$703
- Lilly USA, LLC$700
- GSK$616
- AstraZeneca$454
- plus $4K from 43 others
What the payments were for
- Food & beverage$8,480100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$122
- RYBELSUS$108
How this compares
$8,480 in reported general payments places this provider in the 90th percentile of 766 medical providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 56 | $109,347 |
| EliquisApixaban | 85 | $94,275 |
| JardianceEmpagliflozin | 71 | $86,022 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $39,182 |
| Breo ElliptaFluticasone/Vilanterol | 44 | $36,631 |
| MounjaroTirzepatide | 29 | $34,088 |
| TrulicityDulaglutide | 23 | $30,524 |
| XareltoRivaroxaban | 18 | $27,957 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $22,610 |
| BelsomraSuvorexant | 16 | $18,538 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 50 | $15,338 |
| MyrbetriqMirabegron | 22 | $13,943 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 55 | $10,347 |
| Humalog Kwikpen U-100Insulin Lispro | 40 | $10,243 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $9,251 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,150 | $109,34756 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arexvy, Shingrix | $616 | $95,396145 claims |
| PfizerEliquis | $405 | $94,27585 claims |
| Boehringer IngelheimJardiance | $758 | $86,02271 claims |
| Lilly USA, LLCMounjaro, Trulicity | $700 | $64,61252 claims |
| Johnson & JohnsonXarelto | $158 | $27,95718 claims |
| MerckBelsomra | $133 | $18,53816 claims |
| Astellas Pharma US IncMyrbetriq | $147 | $13,94322 claims |
| AbbVieSynthroid | $703 | $1,92530 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 766 medical providers in Colorado.
Other medical in Wheat Ridge
- Christen KutzColorado Springs$610K
- Amanda MixonFort Collins$342K
- Kristin RyggColorado Springs$255K
- Jordan MastDenver$247K
- John NovakAurora$173K
- Michelle BarnettColorado Springs$138K
- Michael JacobsonFort Collins$131K
- Lindsey TunstallAurora$87K
- Jennifer NafzigerHighlands Ranch$80K
- Daniel TaylorDenver$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.